Literature DB >> 10968706

Immunohistochemistry in the diagnosis of neoplasms of the central nervous system.

C D Morrison1, R A Prayson.   

Abstract

The diagnosis and evaluation of neoplasms of the central nervous system frequently involves the use of immunohistochemical stains. This article reviews some of the more commonly used markers including glial fibrillary acidic protein, synaptophysin, neurofilament protein, S-100 protein, epithelial membrane antigen, and cytokeratin markers. The focus of the discussion is on the use of these markers including their utility in resolving differential diagnostic issues. We also review the use of p53 and a variety of cell proliferation markers including proliferating cell nuclear antigen, Ki-67, MIB-1 and their potential role as adjuncts in the grading of tumors and their potential role in predicting tumor behavior.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968706

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  4 in total

1.  Immunophenotyping of Tumours.

Authors:  R Lakhtakia; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line.

Authors:  André A Schenka; Camila M L Machado; Mariângela C Grippo; Luciano S Queiroz; Natália G M Schenka; Cristiano A Chagas; Liana Verinaud; Pierre Brousset; José Vassallo
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

3.  Long-term effects of estradiol replacement in the olfactory system.

Authors:  Britto P Nathan; Michael Tonsor; Robert G Struble
Journal:  Exp Neurol       Date:  2012-06-09       Impact factor: 5.330

4.  In vitro Analysis of Neurospheres Derived from Glioblastoma Primary Culture: A Novel Methodology Paradigm.

Authors:  Lorena Favaro Pavon; Luciana C Marti; Tatiana Tais Sibov; Suzana M F Malheiros; Reynaldo Andre Brandt; Sergio Cavalheiro; Lionel F Gamarra
Journal:  Front Neurol       Date:  2014-01-07       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.